Market Movers

China Tower’s Stock Price Soars to 0.96 HKD, Marking a Robust 2.13% Uptick in Performance

By September 13, 2024 No Comments

China Tower (788)

0.96 HKD +0.02 (+2.13%) Volume: 56.69M

China Tower’s stock price is currently at 0.96 HKD, experiencing a positive shift of +2.13% this trading session with a substantial trading volume of 56.69M. This promising performance extends its year-to-date increase to +17.07%, showcasing a strong investment opportunity in the telecom infrastructure sector.


Latest developments on China Tower

China Tower (00788) experienced a bullish block trade today, with 6 million shares being traded at $0.94, resulting in a turnover of $5.64 million. This significant transaction reflects investor confidence in the company, potentially leading to positive movements in the stock price. As one of the leading telecommunication tower companies in China, China Tower’s stock price may see an uptick following this block trade, indicating a positive outlook for the company in the market.


China Tower on Smartkarma

Analyst coverage on China Tower on Smartkarma indicates potential changes in the iShares China Large-Cap (FXI) ETF. According to Brian Freitas, China Tower (788 HK) is likely to replace China International Capital Corporation (3908 HK) in the upcoming rebalance on 20th September. Passives may need to buy 2x ADV in China Tower, as shorts have been covering this stock while increasing in CICC. The listing of Midea Group Co Ltd A (000333 CH) H-shares could also impact the ETF before the scheduled rebalance in December.

In another report by Brian Freitas, the preview for the FXI rebalance suggests that China Tower (788 HK) has a high probability of inclusion while CICC (3908 HK) is expected to be deleted from the ETF. Shorts have been dropping in China Tower and increasing in CICC, with a noticeable slowdown in cumulative excess volume for both stocks in recent months. The analysis indicates that there may be just one change for the FXI ETF in September, with the potential for an additional change if Wuxi Apptec underperforms other stocks by 3% over the next 4 weeks.


A look at China Tower Smart Scores

FactorScoreMagnitude
Value5
Dividend4
Growth4
Resilience2
Momentum3
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Tower Corporation Limited, a telecommunication company operating in China, seems to have a promising long-term outlook based on its Smartkarma Smart Scores. With top marks in Value and strong scores in Dividend and Growth, the company appears to be well-positioned for future success in the industry. However, its lower scores in Resilience and Momentum may pose some challenges that need to be addressed to ensure sustained growth and competitiveness in the market.

Despite facing some hurdles in terms of Resilience and Momentum, China Tower’s overall outlook remains positive, thanks to its solid performance in key areas such as Value, Dividend, and Growth. As a leading provider of telecommunication towers construction and maintenance services in China, the company is well-equipped to capitalize on the growing demand for telecommunications infrastructure in the country. By leveraging its strengths and addressing its weaknesses, China Tower can continue to thrive in the evolving telecommunication landscape.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars